Global perspective of the risks of falsified and counterfeit medicines

Substandard and falsified medical products

Substandard and falsified medical products contribute to antimicrobial resistance and drug-resistant infections. Falsified medical products may ...

Report falsified products - Novo Nordisk

Counterfeit or falsified medicines are an ongoing global issue which poses devastating risks to public health and safety worldwide1. Counterfeit medicines ...

I (Don't) want to consume counterfeit medicines: exploratory study ...

According to estimates, between 10 to 60% of the drugs distributed in the developing world and the vast majority of those sold online in the ...

Falsified medical products - United Nations Office on Drugs and Crime

This guide will contribute to an increased number of national and international investigations and prosecutions of falsified medical product-related crime.

Substandard and falsified medical products: bibliometric analysis ...

... patterns of global research publications on SF products. A bibliometric approach was adopted using terms such as fake, falsified, counterfeit ...

A review of existing and emerging digital technologies to combat the ...

The global counterfeit drug trade: patient safety and public health risks. ... falsified medicines: laboratory and field innovations and ...

Substandard and Falsified Medicines: Proposed Methods for Case ...

The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and ...

Novartis Position on Falsified Medical Products

medical products, the health risks are enormous, as a falsified medicine may not ... We commit to contribute to the global fight against falsified medicinal ...

Prevalence and Estimated Economic Burden of Substandard and ...

The World Health Organization (WHO) estimates that 10.5% of medicines worldwide are substandard or falsified. Furthermore, most of the burden ...

Responding to the Pandemic of Falsified Medicines in

Over the past decade, the number of countries reporting falsified (fake, spurious/falsely labeled/counterfeit) medicines and the types and quantities of ...

Blockchain Technology for Detecting Falsified and Substandard ...

Background: Drug counterfeiting is a global problem with significant risks to consumers and the general public. In the Philippines, 30% of ...

Fighting the global counterfeit medicines challenge: A consumer ...

It is observed that medicine counterfeiting is as big a challenge for the industrialized world as it is for low-income countries and a complementary ...

Public health interventions to protect against falsified medicines

Background: Falsified medicines are deliberately fraudulent drugs that pose a direct risk to patient health and undermine healthcare systems, ...

Fake Drugs 101: Facts on Illegal, Counterfeit Drugs - Pfizer

According to the World Health Organization (WHO), one of every 10 medicines fails in low- and middle-income countries because they are substandard or falsified.

Fake medicines - Interpol

Fake medicines can be dangerous for a number of reasons. Perhaps they have been falsified or deliberately mislabelled. Illicit medicines often contain the wrong ...

Falsified medicines: overview | European Medicines Agency (EMA)

Falsified medicines are fake medicines that pass themselves off as real, authorised medicines. The European Union (EU) has a strong legal ...

Falsified medicines - Public Health - European Commission

As falsified medicines become more sophisticated, the risk of them reaching patients in the EU increases. They represent a serious threat to global health and ...

Global perspective of the risks of falsified and counterfeit medicines

... falsified and counterfeit medicines globally poses risks to international travellers. This narrative literature review examines the global ...

Counterfeit Medications | Global Statistics | Australia Risks - PharmOut

Concerns include falsified laboratory reports, unregulated storage facilities and corruptable distribution channels. An alarming number of ...

Substandard and counterfeit medicines: a systematic review of the ...

The median prevalence of substandard/counterfeit medicines was 28.5% (range 11–48%). Only two studies differentiated between substandard and counterfeit ...